Deerfield Private Design Fund IV, L.P.'s Net Worth

$0

Estimate Recalculated May 19, 2025 08:11PM EST

Who is Deerfield Private Design Fund IV, L.P.

Deerfield Private Design Fund IV, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DFP HEALTHCARE ACQUISITIONS CORP., Nkarta, Inc., Revolution Medicines, Inc., Singular Genomics Systems, Inc., Edgewise Therapeutics, Inc., Nuvalent, Inc., Mirum Pharmaceuticals, Inc., ARVINAS INC., Schrodinger, Inc., AdaptHealth Corp., Larimar Therapeutics, Inc., PROTEON THERAPEUTICS INC, Cabaletta Bio, Inc., Annexon, Inc., Frequency Therapeutics, Inc., and ARS Pharmaceuticals, Inc..

SEC CIK

Deerfield Private Design Fund IV, L.P.'s CIK is 0001680307

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Oncology Institute, Inc.

Investor
Updated Nov 16, 2021
Form 4
460.68%
3.80M
$1,000.00
$100.00M
Nov 16, 2021
7.89M
Purchase
Nov 12
Form 4
5.00M
$10.00
$50.00M
Mar 17, 2020
5.00M
Acq/Dis
Mar 13
Form 3
Mar 10, 2020
Showing 3 results

Nkarta, Inc.

Investor
Updated Jul 14, 2020
Form 4
-53.94%
-2.83M
$18.00
Jul 14, 2020
2.42M
Buy-Options
Jul 14
Form 3
Jul 09, 2020
Showing 2 results

Revolution Medicines, Inc.

Investor
Updated Feb 18, 2020
Form 4
40.10%
600.00K
$17.00
Feb 18, 2020
2.10M
Purchase
Feb 18
Form 3
Feb 12, 2020
Showing 2 results

Singular Genomics Systems, Inc.

Investor
Updated Jun 03, 2021
Form 4
19.71%
1.50M
$19.99
$33.26M
Jun 03, 2021
9.14M
Purchase
Jun 01
Form 3
May 26, 2021
Showing 2 results

Edgewise Therapeutics, Inc.

Investor
Updated Mar 30, 2021
Form 4
18.89%
625.00K
$16.00
Mar 30, 2021
3.93M
Purchase
Mar 30
Form 3
Mar 25, 2021
Showing 2 results

Nuvalent, Inc.

Investor
Updated Oct 24, 2024
Form 4
-10.34%
-2.00M
$97.75
-$195.50M
Oct 24, 2024
17.99M
Sale
Oct 22
Form 4
650.00K
$33.50
$21.78M
Nov 07, 2022
19.99M
Purchase
Nov 03
Form 4
-80.59%
-102.90M
$17.00
Aug 04, 2021
24.78M
Buy-Options
Aug 02
Form 3
Jul 28, 2021
557.40K
Showing 4 results

Mirum Pharmaceuticals, Inc.

Investor
Updated Jun 08, 2022
Form 4
-1.17%
-38.48K
$25.01
-$962.26K
Jun 08, 2022
3.24M
Sale
Jun 06
Form 4
-100.00%
-99.33K
$15.81
-$1.57M
Jul 13, 2021
3.28M
Sale
Jul 09
Form 4
-40.17%
-66.67K
$16.29
-$1.09M
Jul 07, 2021
3.38M
Sale
Jul 02 - Jul 07
Form 4
-86.17%
-21.49M
$15.00
$2.49M
Jul 24, 2019
3.45M
Buy-Options
Jul 22
Form 3
Jul 17, 2019
Showing 5 results

ARVINAS INC.

Investor
Updated Oct 01, 2018
Form 4
-58.79%
-1.76M
$16.00
Oct 01, 2018
1.23M
Buy-Options
Oct 01
Form 3
Sep 26, 2018
Showing 2 results

Schrodinger, Inc.

Investor
Updated Feb 10, 2020
Form 4
-84.14%
-8.47M
$17.00
$4.25M
Feb 10, 2020
1.60M
Buy-Options
Feb 10
Form 3
Feb 05, 2020
Showing 2 results

AdaptHealth Corp.

Investor
Updated Mar 12, 2024
Form 4
-2.95%
-350.00K
$10.90
-$3.82M
Mar 12, 2024
13.26M
Sale
Mar 08 - Mar 12
Form 3
Mar 08, 2024
13.61M
Form 4
149.22%
11.28M
$10.00
$124.00M
Nov 13, 2019
19.67M
Acquisition
Nov 08
Form 4
-13.23%
-925.76K
Apr 04, 2018
8.57M
Disposition
Apr 02
Form 4
7.67M
$1.50
$6.50M
Feb 23, 2018
14.66M
Purchase
Feb 21
Form 3
Feb 15, 2018
7.00M
Showing 6 results

Larimar Therapeutics, Inc.

Investor
Updated Feb 16, 2024
Form 4
35.11%
4.29M
$8.74
$37.50M
Feb 16, 2024
21.23M
Purchase
Feb 16
Form 4
190.58%
11.11M
$3.15
$35.00M
Sep 20, 2022
16.94M
Purchase
Sep 16
Form 4
13.33%
685.71K
$8.75
$6.00M
Jul 02, 2021
5.83M
Purchase
Jun 30
Form 3
Jun 08, 2020
6.09M
Showing 4 results

PROTEON THERAPEUTICS INC

Investor
Updated Aug 04, 2017
Form 3
Aug 04, 2017
1.22M
Showing 1 results

Cabaletta Bio, Inc.

Investor
Updated Oct 30, 2019
Form 4
16.93%
235.75K
$11.00
$7.70M
Oct 30, 2019
1.63M
Purchase
Oct 29
Form 3
Oct 24, 2019
Showing 2 results

Annexon, Inc.

Investor
Updated Jul 28, 2020
Form 4
-79.99%
-6.47M
$17.00
Jul 28, 2020
1.62M
Buy-Options
Jul 28
Form 3
Jul 23, 2020
Showing 2 results

Frequency Therapeutics, Inc.

Investor
Updated Oct 07, 2019
Form 4
-80.67%
-5.14M
$14.00
$4.00M
Oct 07, 2019
1.23M
Buy-Options
Oct 07
Form 3
Oct 02, 2019
Showing 2 results

ARS Pharmaceuticals, Inc.

Investor
Updated Nov 10, 2022
Form 3
Nov 10, 2022
11.08M
Showing 1 results